Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Auregen BioTherapeutics SA

Home Clinical Trial Sponsors and OrganizationsAuregen BioTherapeutics SA

Auregen BioTherapeutics SA

ACTIVE

Avenue Giuseppe-Motta 31-37, Genève, SwitzerlandHolding1–10 employeesEstablished: 2016-12-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

100.0%

Trial Status Distribution

Terminated

3

100.0%

Clinical Trials

Trials sponsored by this organization (3)

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201

Jan 20241 participant

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

Jan 20243 participants

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)

Nov 20222 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations